HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer Cells
- Type
- Retraction
- Notice date
- 5/16/2022 0:00
- Journal
- Human Gene Therapy
- Publisher
- Taylor and Francis
- Notice DOI
- 10.1089/hum.2017.256.retract
- Original paper DOI
- 10.1089/hum.2017.256